ETH 625
Pill imprint ETH 625 has been identified as Oxycodone hydrochloride 5 mg.
Oxycodone is used in the treatment of pain and belongs to the drug class narcotic analgesics. FDA has not classified the drug for risk during pregnancy.
Oxycodone 5 mg has a high potential for abuse. The drug has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse of the drug may lead to severe psychological or physical dependence.
See also related documents.
Oxycodone hydrochloride Images
- Imprint:
-
ETH
625 - Strength:
- 5 mg
- Color:
- Orange
- Size:
- 6.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- magnesium stearate
microcrystalline cellulose
silicon dioxide
stearic acid
D&C Red No. 30
D&C Yellow No. 10
- Drug Class:
- Narcotic analgesics
- Pregnancy Category:
- N - Not yet classified
- CSA Schedule:
- 2 - High potential for abuse
- Manufacturer:
- Ethex Corporation
- National Drug Code (NDC):
- 58177-0625
| NDC Code | Manufacturer / Repackager |
|---|---|
| 66336-0174 | Dispensing Solutions Inc. (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Oxycodone Hydrochloride resources
- Oxycodone
- Oxycodone (Wolters Kluwer)
- Oxycodone Concentrate (Wolters Kluwer)
- Oxycodone Solution (Wolters Kluwer)
- Oxycodone Sustained-Release Tablets (Wolters Kluwer)
- oxycodone (Cerner Multum)
- Oxy IR (Micromedex) - Includes Dosage Information
- Oxycontin CR (Micromedex) - Includes Dosage Information
- oxycodone (Micromedex) - Includes Dosage Information
- Oxycodone (AHFS DI)
- Oxycodone Hydrochloride (AHFS DI)
- Oxycodone (FDA)
- Oxycodone Capsules (FDA)
- Oxycodone ER (FDA)
- Oxycodone Extended-Release Tablets (FDA)
- Oxycodone Immediate-Release Capsules (FDA)
- Oxycodone Solution (FDA)
- Oxycodone Solution Concentrate (FDA)
- Oxycodone Hydrochloride (Wolters Kluwer)
Search Again
